[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"shoulder-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:shoulder-disease":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,42,64,92,121,148],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100625331","osseofit-stemless-shoulder-system-anatomic-100625331",false,"NCT07421245","OsseoFit Stemless Shoulder System (Anatomic)","OsseoFit Stemless Shoulder System (Anatomic) Post-Market Clinical Follow-up Study","Inclusion Criteria:\n\n* Patient must be 20 years of age or older.\n* The patient must be anatomically and structurally suited, as evident by scapula and proximal humerus closure, to receive the implants.\n* Patient planned to receive OsseoFit™ anchor with uncemented fixation.\n* Patient planned to receive a Modular Alliance Glenoid with bone cement. The porous posts must be coated with Porous Plasma Spray (PPS) and may be inserted without bone cement.\n* Patient planned to receive shoulder arthroplasty due to osteoarthritis.\n* Patient must be able and willing to complete the protocol required follow-up schedule.\n* Patient must be able and willing to sign the IRB approved consent.\n\nExclusion Criteria:\n\n* Patient is unwilling or unable to give consent or to comply with the follow-up program.\n* Patient has any condition which would in the judgement of the Investigator, place the patient at undue risk or interfere with the study.\n* Patient is known to be pregnant or breastfeeding.\n* Patient is a vulnerable participant (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, and\u002For anticipated to be non-compliant).\n* Patient is uncooperative or patient with neurologic disorders who is incapable or unwilling to follow directions.\n* Patient has any neuromuscular disease compromising the affected limb.\n* Patient has any sign of infection affecting the shoulder joint or in its proximity which may spread to the implant site. This may include:\n\n  * Local\u002Fsystemic infection\n  * Sepsis\n  * Osteomyelitis\n* Patient presents with Osteomalacia.\n* Patient presents with a humeral bone fracture.\n* Patient presents with malunion or non-union of the tuberosities of the proximal humerus.\n* Patient has had a previous operative shoulder prosthesis (stem or stemless).\n* Patient has irreparable cuff tear.\n* Patient presents with inadequate humeral bone, which in the opinion of the Investigator, may lead to poor implant fixation. This may include but is not limited to:\n\n  * Osteoporosis\n  * Extensive Avascular Necrosis\n  * Rheumatoid Arthritis\n  * Metaphyseal bony defects (including large cysts)","ALL","20 Years",{"count":19,"type":20},136,"ESTIMATED","OBSERVATIONAL","The purpose of this clinical research protocol is to evaluate the safety, efficacy, and long-term outcomes of the OsseoFit Stemless Shoulder System (Anatomic) in patients with a primary diagnosis of osteoarthritis. The study aims to assess the intraoperative characteristics, postoperative complications, functional outcomes, and radiographic findings associated with the use of the stemless implant system. Ultimately, this research aims to improve patient outcomes, enhance surgical techniques, and inform clinical decision-making in the treatment of shoulder pathology.",[24,25,26,27,28],"Shoulder Injuries","Shoulder Pain","Shoulder Fractures","Shoulder Arthritis","Shoulder Disease","NOT_YET_RECRUITING","2026-04-22",{"date":32,"type":33},"2026-04-23","ACTUAL",{"date":35,"type":20},"2026-04",{"date":37,"type":20},"2036-01",{"name":39,"class":40},"Zimmer Biomet","INDUSTRY",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":16,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},"100576701","mdr---comprehensive-primary-revision-stems-pmcf-100576701","NCT06788717","MDR - Comprehensive Primary Revision Stems PMCF","Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Comprehensive® Primary Revision Stems (Implants and Instrumentation) - A Retrospective and Prospective Consecutive Series Study","Inclusion Criteria\n\n* Patient must be 18 years of age or older.\n* Patient must be willing and able to follow directions.\n* Study devices must have been implanted following the surgical technique and IFU for the Comprehensive Revision Stem\n\nExclusion Criteria\n\n* Off-label use.\n* Patient is a prisoner.\n* Patient is a current alcohol or drug abuser.\n* Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent.\n* Patient is unwilling to sign informed consent.\n* Uncooperative patient or patient with neurologic disorders who are incapable of following directions.","18 Years","100 Years",{"count":52,"type":20},59,"The objective of this retrospective and prospective consecutive series PMCF (Post Market Clinical Follow Up) study is to collect long-term data confirming safety, performance and clinical benefits of the Comprehensive Primary Revision Stems (implants and instrumentation) when used for shoulder arthroplasty at 1, 3, 5, 7 and 10 years.",[25,24,26,28,27],"RECRUITING",{"date":57,"type":33},"2026-04-28",{"date":59,"type":33},"2025-06-19",{"date":61,"type":20},"2040-12",{"name":39,"class":40},2,{"id":65,"slug":66,"hasResults":11,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":11,"sex":16,"minAge":49,"maxAge":4,"enrollmentInfo":71,"targetDuration":4,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":78,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":63},"100517339","using-virtuacaretm-platform-for-home-programs-in-acute-and-chronic-shoulder-conditions-a-pilot-study-100517339","NCT06016257","Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study","VirtuaCare","Inclusion Criteria:\n\nPhysical therapy home program subjects\n\n* Subject 18 years or older\n* Outpatient physical therapy prescribed by doctor for shoulder rehabilitation.\n* No previous neurological condition\n* Understand English (exercises are only in English) Physical therapists\n* The therapists will be the ones who provide physical therapy treatment to the acute and chronic shoulder population.\n\nPatients who had usual and customary treatment for acute and chronic shoulder conditions\n\n• Any patient referred based on inclusion criteria noted above that are referred for outpatient physical therapy and had a previous acute or chronic shoulder condition, were 18 years and older and had no previously documented neurological condition.\n\nExclusion Criteria:\n\nPhysical therapy home program subjects\n\n* Prior surgery within the last 5 years or less than 6 months between surgery\n* Neurologic comorbidities that have functional deficits\n* Uncontrolled diabetes\n* Diagnosis with active cancer in the last two years\n* Unable to understand English\n\nPhysical therapists • Any therapist who does not provide physical therapy treatment for acute and chronic shoulder conditions.\n\nPatients who had usual and customary treatment for acute and chronic shoulder conditions\n\n• Any patient who had prior surgery within the last 5 years or less than 6 months between surgery, had neurological comorbidities that had documented functional deficits, documented uncontrollable diabetes, documented diagnosis of active cancer within the last two years.",{"count":72,"type":20},20,"INTERVENTIONAL",[75],"NA","This study will be performed to determine if Band Connect's VirtuaCare™ platform increases patient compliance and provides an effective alternative to current physical therapy treatment while reducing the frequency of visits compared with standard orthopedic physical therapy treatment performed in the outpatient clinic.\n\nParticipants are being asked to take part in this research study if 18 years and older and have been prescribed physical therapy rehabilitation for an acute or chronic shoulder condition and as part of the participant's physical therapy will receive a shoulder exercise home program.",[28,24],[79,80,81],"Home program","Shoulder conditions","Adherence","2026-03-23",{"date":84,"type":33},"2026-03-27",{"date":86,"type":33},"2024-02-01",{"date":88,"type":20},"2026-12-31",{"name":90,"class":91},"Cedars-Sinai Medical Center","OTHER",{"id":93,"slug":94,"hasResults":11,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":98,"eligibilityCriteria":99,"healthyVolunteers":11,"sex":16,"minAge":49,"maxAge":4,"enrollmentInfo":100,"targetDuration":4,"studyType":73,"phases":102,"briefSummary":103,"conditions":104,"keywords":108,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":4},"100620097","comparison-of-the-effectiveness-of-tens-and-tens--nmes-treatment-in-stroke-patients-with-shoulder-pain-100620097","NCT07353190","Comparison of the Effectiveness of TENS and TENS + NMES Treatment in Stroke Patients With Shoulder Pain","Comparison of the Effectiveness of TENS and TENS + NMES Treatment in Stroke Patients With Shoulder Pain: Prospective Randomized Controlled Study","TENS","Inclusion Criteria:\n\n* Individuals aged 18 and over\n* Patients with a history of clinically and radiologically confirmed ischemic or hemorrhagic stroke\n* Hemiplegic shoulder pain in the affected shoulder\n* Shoulder pain severity VAS\u002FNRS ≥ 2\n* At least 2 weeks and at most 1 year have passed since the onset of stroke\n* Have a level of cognitive and communicative competence that will not hinder the application of clinical evaluations and scales\n* Must have signed the Informed Volunteer Consent Form to participate in the study.\n* Must have a general medical condition to participate in a conventional rehabilitation program\n\nExclusion Criteria:\n\n\\-",{"count":101,"type":20},40,[75],"In this study, the effects of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (TENS + NMES) applied in addition to TENS on pain, shoulder joint range of motion and upper extremity functions will be comparatively evaluated in stroke patients with hemiplegic shoulder pain. In this direction, in the study; The effectiveness of both treatment approaches on the severity of hemiplegic shoulder pain, their contribution to shoulder functionality and daily living activities will be examined; It will be investigated whether NMES application added to TENS provides an additional clinical benefit compared to TENS.",[105,28,106,107],"Stroke","Hemiplegia","Hemiplegic Shoulder Pain",[109,110,98,111],"stroke","shoulder pain","NMES","2026-01-15",{"date":114,"type":33},"2026-01-20",{"date":116,"type":20},"2026-02-01",{"date":118,"type":20},"2026-06-30",{"name":120,"class":91},"Medical Park Bursa Hospital",{"id":122,"slug":123,"hasResults":11,"nctId":124,"briefTitle":125,"officialTitle":126,"acronym":4,"eligibilityCriteria":127,"healthyVolunteers":11,"sex":16,"minAge":49,"maxAge":128,"enrollmentInfo":129,"targetDuration":4,"studyType":73,"phases":131,"briefSummary":132,"conditions":133,"keywords":134,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":139,"lastUpdatePostDateStruct":140,"startDateStruct":142,"completionDateStruct":144,"leadSponsor":146,"locationsCount":41},"100614319","interscalene-block-vs-serratus-posterior-superior-intercostal-plane-block-100614319","NCT07278050","Interscalene Block vs Serratus Posterior Superior Intercostal Plane Block","Interscalene Block vs Serratus Posterior Superior Intercostal Plane Block on Postoperative Analgesia Management After Arthroscopic Shoulder Surgery: A Randomized Prospective Study","Inclusion Criteria:\n\n* American Society of Anesthesiologists (ASA) classification I-II\n* Scheduled for arthroscopic shoulder surgery under general anesthesia\n\nExclusion Criteria:\n\n* history of bleeding diathesis,\n* receiving anticoagulant treatment,\n* known local anesthetics and opioid allergy,\n* infection of the skin at the site of the needle puncture,\n* pregnancy or lactation,\n* patients who do not accept the procedure","75 Years",{"count":130,"type":20},60,[75],"Postoperative pain is important following arthroscopic shoulder surgery. Postoperative effective pain treatment provides early mobilization and a shorter hospital stay. Ultrasound (US)-guided brachial plexus blocks, such as interscalene and supraclavicular block, are usually performed. Interscalen brachial plexus block (ISCB) is one of the most preferred techniques among these.\n\nUltrasound (US) guided serratus posterior superior block (SPSPB) is a new interfacial plane block defined by Tulgar et al in 2023. It is based on injection on the serratus posterior superior muscle at the level of the 2nd or 3rd rib. This block provides analgesia in conditions such as interscapular pain, chronic myofascial pain syndromes, scapulocostal syndrome, and shoulder pain. The SPS muscle is located at the C7-T2 level. It attaches to the lateral edges of the second and fifth ribs. It is innervated by the lower cervical and upper intercostal nerves. With the SPS block, these nerves are blocked, and analgesia is provided. It has been reported that SPSIPB provides effective analgesia after shoulder surgery.\n\nThe aim of this study is to compare the efficacy of the US-guided SPSIPB and ISCB for postoperative analgesia management after arthroscopic shoulder surgery.",[25,28],[135,136,137,138],"Arthroscopic Shoulder Surgery","Postoperative analgesia management","serratus posterior superior intercostal plane block","Interscalene brachial plexus block","2026-01-13",{"date":141,"type":33},"2026-01-14",{"date":143,"type":33},"2026-01-10",{"date":145,"type":20},"2026-10-25",{"name":147,"class":91},"Medipol University",{"id":149,"slug":150,"hasResults":11,"nctId":151,"briefTitle":152,"officialTitle":152,"acronym":4,"eligibilityCriteria":153,"healthyVolunteers":11,"sex":16,"minAge":49,"maxAge":154,"enrollmentInfo":155,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":156,"conditions":157,"keywords":164,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":169,"lastUpdatePostDateStruct":170,"startDateStruct":172,"completionDateStruct":174,"leadSponsor":176,"locationsCount":41},"100378588","evaluating-hemidiaphragmatic-paralysis-with-prolonged-neural-blockade-from-an-interscalene-brachial-plexus-block-100378588","NCT04209504","Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block","Inclusion Criteria:\n\n* English speaking 18-80 year old ASA 1-3 patients\n* Primary shoulder surgery\n* Must live within a 25 mile radius\n\nExclusion Criteria:\n\n* ASA 4 or 5\n* Revision shoulder surgery\n* Diagnosis of chronic pain\n* Daily chronic opioid use (over 3 months of continuous opioid use)\n* Inability to communicate pain scores or need for analgesia\n* Infection at the site of block placement\n* Age under 18 years old or greater than 80 years old\n* Pregnant women (as determined by point-of-care serum bHCG)\n* Intolerance\u002Fallergy to local anesthetics\n* Weight \\\u003C50 kg\n* BMI \\> 40\n* severe pulmonary disease including chronic obstructive pulmonary disease and restrictive lung disease\n* Suspected, or known addiction to or abuse of illicit drug(s), prescription medicine(s), or alcohol within the past 2 years.\n* Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the opinion of the investigator, may interfere with study assessments or compliance.\n* Current or historical evidence of any clinically significant disease or condition that, in the opinion of the investigator, may increase the risk of surgery or complicate the subject's postoperative course.","80 Years",{"count":130,"type":20},"This prospective observational study aims to evaluate the incidence of hemidiaphragmatic paralysis in patients receiving interscalene brachial plexus nerve block with prolonged neural blockade. English speaking American Society of Anesthesiologists (ASA) 1-3 patients ages 18-80 receiving prolonged interscalene nerve block will be randomized into 3 groups: first group receiving a perineural catheter infusing 0.2% ropivacaine; the second group receiving a single shot injection of 10mL liposomal bupivacaine (Exparel; n=20) plus 5 mL 0.5% bupivacaine and the third receiving 20mL liposomal bupivacaine plus 5mL bupivacaine (to be determined by the attending anesthesiologist).Primary outcome will be incidence of hemidiaphragmatic paralysis postoperative day 1 as measured by point of care (POCUS) ultrasound.",[158,25,24,27,28,159,160,161,162,163],"Shoulder Surgery","Rotator Cuff Tears","Rotator Cuff Injuries","Rotator Cuff Arthropathy of Left Shoulder","Rotator Cuff Arthropathy of Right Shoulder","Rotator Cuff Repair",[163,158,165,166,167,168],"Hemidiaphragmatic paralysis","Interscalene Block","Interscalene Catheter","Interscalene Liposomal Bupivacaine","2025-09-29",{"date":171,"type":33},"2025-10-01",{"date":173,"type":33},"2021-10-12",{"date":175,"type":20},"2026-08-31",{"name":177,"class":91},"Duke University"]